Evidence map›Paper›PMID 42129018›Full record

ArticleTherapeutic innovation & regulatory science2026

Evaluation of Ease of Use for Pediatric Medications Requiring Decapsulation, Dissolution, or Partial Dosing: A Questionnaire-Based Study in Japan.

Jumpei Saito, Akimasa Yamatani, Hidefumi Nakamura, Miki Akabane

Abstract read
PubMed Publisher
In one paragraph

Article in Therapeutic innovation & regulatory science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jumpei SaitoDepartment of Pharmacy, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan. saito-jn@ncchd.go.jp.
Akimasa YamataniPediatric and Perinatal Medicine, Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose-shi, Tokyo, 204-0004, Japan.
Hidefumi NakamuraDepartment of Research and Development Supervision, Clinical Research Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.
Miki AkabaneDepartment of Pharmacy, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSolid dosage forms such as fine granules, mini-tablets, and micropellets are gaining popularity worldwide because of their longer shelf lives, lower need for preservatives, and precise dosing compared to liquids. However, international pediatric formulations are often liquids or powders, and it is unclear whether these offer advantages over single-dose packaging, which is used in Japan, for caregiver management, preparation, administration, and cleanup. The acceptability of solid forms that require extra preparation, such as decapsulation, weighing dissolved powders, or taking partial doses, remains uncertain. This study evaluated the acceptability and usability of new dosage forms that involve caregiver preparation.

methodsFrom April 2024 to November 2025, a survey was conducted among parents and caregivers of pediatric patients aged 0-18 years visiting the National Center for Child Health and Development. The survey focused on formulations involving opening capsules, preparing suspensions, and administering partial doses. Four model formulations were selected and evaluated: tacrolimus capsules (A), mycophenolic acid powder (B), valganciclovir dry syrup (C), and desmopressin oral disintegrating tablets (D). Respondents rated management, preparation, administration, and cleanup on an 11-point scale (- 50 to + 50) compared to conventional powders. Descriptive statistics and 95% confidence intervals were used.

resultsA total of 312 responses were analyzed. The median patient age ranged from 3.6 to 4.6 years. Tacrolimus (A) scored highest for management but lowest for preparation. Mycophenolate mofetil (B) was considered burdensome for management and cleanup, though it was easy to administer. Valganciclovir (C) showed similar trends, with storage challenges. Desmopressin (D) was easy to manage but difficult to prepare and administer. While managing capsules and tablets was seen as convenient, the complexity of decapsulation and dissolving tablets for administration was noted. Dissolution powders indicated potential management difficulties.

conclusionDissolution suspension forms were viewed as more challenging to manage than powders. Preparation and administration were burdensome for all, especially those requiring dissolution and partial dosing. Caregiver-friendly designs are ideal, but establishing the infrastructure for timely delivery and acceptance in clinics is essential.

Indexed as

Dosage FormsDrug CompoundingAdolescentCapsulesCaregiversChildChild, PreschoolFemaleHumansInfantInfant, NewbornJapanMaleMycophenolic AcidPowdersSolubilityCapsulesDosage FormsMycophenolic AcidPowdersTabletsTacrolimusAdministrationFormulationManagementPediatricsPowderPreparation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.